Bottleneck Analysis

Bottleneck Analysis designates systematic identification of rate-limiting steps, capacity constraints, or performance-limiting factors within manufacturing, clinical, or analytical processes that restrict overall throughput, efficiency, or quality, enabling targeted improvement investments maximising process performance with available resources.

The biopharmaceutical industry applies bottleneck analysis throughout manufacturing and development operations. Process mapping identifies steps where throughput is constrained by equipment capacity, cycle times, or resource availability. Statistical process control data reveal steps exhibiting highest variability impacting batch quality or yield. Clinical trial bottleneck analysis identifies limiting factors in patient recruitment, site activation, or data management affecting development timelines. Supply chain bottleneck analysis identifies single-source materials or capacity-constrained suppliers creating vulnerability. Value stream mapping visualises material and information flow highlighting non-value-adding steps. Simulation modelling quantifies bottleneck impacts under different demand scenarios. As manufacturing networks become more complex and development timelines compress, systematic bottleneck analysis continues enabling efficient resource allocation and process improvement.